HC Wainwright Predicts Lower Earnings for Vivani Medical

Vivani Medical, Inc. (NASDAQ:VANI) – Investment analysts at HC Wainwright decreased their FY2024 earnings per share estimates for shares of Vivani Medical in a research note issued to investors on Thursday, March 13th. HC Wainwright analyst Y. Chen now expects that the company will earn ($0.43) per share for the year, down from their prior estimate of ($0.41). HC Wainwright currently has a “Buy” rating and a $4.00 target price on the stock. The consensus estimate for Vivani Medical’s current full-year earnings is ($0.41) per share. HC Wainwright also issued estimates for Vivani Medical’s Q1 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.09) EPS, Q4 2025 earnings at ($0.09) EPS and FY2025 earnings at ($0.39) EPS.

Vivani Medical Stock Down 0.9 %

Shares of NASDAQ:VANI opened at $1.09 on Monday. The firm has a market cap of $64.57 million, a P/E ratio of -2.42 and a beta of 3.20. Vivani Medical has a 12-month low of $1.03 and a 12-month high of $2.22. The business has a fifty day simple moving average of $1.15 and a 200 day simple moving average of $1.22.

Institutional Trading of Vivani Medical

A number of large investors have recently bought and sold shares of the business. Wealthedge Investment Advisors LLC acquired a new stake in Vivani Medical during the 4th quarter worth about $43,000. Jane Street Group LLC acquired a new stake in shares of Vivani Medical in the 4th quarter valued at about $66,000. Northern Trust Corp grew its stake in shares of Vivani Medical by 19.1% in the 4th quarter. Northern Trust Corp now owns 71,915 shares of the company’s stock valued at $83,000 after buying an additional 11,540 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of Vivani Medical by 4.6% in the 3rd quarter. Geode Capital Management LLC now owns 342,891 shares of the company’s stock valued at $401,000 after buying an additional 15,008 shares during the period. 6.78% of the stock is currently owned by institutional investors and hedge funds.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.